Search clinical trials for: Diffuse Large B Cells Lymphoma (DLBCL)
Total 490392 results
-
Hospices Civils de LyonCompletedTo Characterize and Compare Clinical, Pathological and Molecular FeaturesFrance
-
Memorial Sloan Kettering Cancer CenterActinium PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-ALL | DLBCL | DLBCL, Nos Genetic Subtypes | B ALL | Dlbcl-Ci | DLBCL Unclassifiable | DLBCL Activated B-Cell Type | DLBCL Germinal Center B-Cell Type | HGBL | HGBL, NosUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell LymphomaItaly
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingDiffuse Large B-cell LymphomaChina
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLC; Celgene CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom, Belgium, Germany
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
First Affiliated Hospital of Zhejiang UniversityUnknown
-
CelltrionTerminatedDiffuse Large B-Cell LymphomaKorea, Republic of
-
Inje UniversityUnknownNon Hodgkin's LymphomaKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
Rush University Medical CenterElsa U. Pardee FoundationTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
MorphoSys AGIqvia Pty LtdRecruitingDiffuse Large B-cell LymphomaUnited States
-
University Hospital TuebingenHoffmann-La RocheCompletedPrimary Gastric Diffuse-Large B-Cell LymphomaGermany
-
Genelabs TechnologiesUnknownLupusUnited States, Mexico
-
Shandong New Time Pharmaceutical Co., LTDRecruiting
-
Beijing InnoCare Pharma Tech Co., Ltd.Completed
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
Fudan UniversityTerminated
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompletedLymphoma, Large B-Cell, DiffuseAustria
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Beijing Yongtai Ruike Biotechnology Company LtdRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
Pell Bio-Med Technology Co., Ltd.RecruitingDiffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3ATaiwan
-
Fujian Medical UniversityActive, not recruitingDiffuse Large B-cell LymphomaChina
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Gruppo Italiano Terapie Innovative nei LinfomiCompletedDiffuse Large B-Cell LymphomaItaly
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDiffuse Large B-cell Lymphoma
-
National Research Center for Hematology, RussiaNational Research Center for HematologyRecruiting
-
Hospices Civils de LyonCompleted
-
Ruijin HospitalShanxi Province Cancer Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsRecruiting
-
Nanfang Hospital of Southern Medical UniversityRecruiting
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
Sun Yat-sen UniversityCompletedDiffuse Large B-cell Lymphoma
-
Sichuan UniversityUnknown
-
Sohag UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
Wuhan UniversityRecruitingDiffuse Large B-cell LymphomaChina
-
Ruijin HospitalNot yet recruitingDiffuse Large B Cell Lymphoma
-
Fudan UniversityUnknown
-
AstraZenecaCompletedDiffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Arbeitsgemeinschaft medikamentoese TumortherapieHoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma (DLBCL) | Follicular NHL Grade 3bHong Kong, Thailand, Sweden, Taiwan, Mexico, Austria, Serbia, China, Czech Republic, Australia, Malaysia, Croatia, Israel, South Africa, Bosnia and Herzegovina, Brazil, Bulgaria, Estonia, Latvia, Macedonia, The Former Yugoslav... and more